vimarsana.com

Latest Breaking News On - Motohiro ebisawa - Page 1 : vimarsana.com

Motohiro Ebisawa, MD, PhD: Phase 3 Findings on Neffy for Pediatric Patients At-Risk of Anaphylaxis

In this interview, Ebisawa discusses his team’s recent research into the frequently-discussed non-injector epinephrine alternative neffy.

Students with food allergies rose 120,000 over past decade | The Asahi Shimbun: Breaking News, Japan News and Analysis

Around 527,000 students in public schools across Japan suffer from food allergies according to a recent survey, an increase of about 120,000 students from the previous survey nine years ago.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.